Rising Star: DLA Piper's Heidi Levine

Law360, New York (March 26, 2010, 5:11 PM EDT) -- DLA Piper partner Heidi Levine has played a leading role in defending several major pharmaceutical companies in mass torts, including litigation over GE Healthcare's contrast agent Omniscan and Wyeth Inc.'s diet drug fen-phen, earning her a place among Law360's 10 product liability lawyers under 40 to watch.

Levine, who is co-chair of DLA Piper's New York mass torts practice group, focuses her work primarily on pharmaceutical cases. She is involved in several ongoing cases, including as lead national counsel in the Omniscan litigation, which is headed...
To view the full article, register now.